MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway
出版年份 2019 全文链接
标题
MicroRNA-326 Functions as a Tumor Suppressor in Breast Cancer by Targeting ErbB/PI3K Signaling Pathway
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-07-30
DOI
10.3389/fonc.2019.00653
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1
- (2017) Shiping Hu et al. ONCOLOGY REPORTS
- MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways
- (2017) Kang Kang et al. ONCOLOGY REPORTS
- MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma
- (2016) Lei Cao et al. BIOMEDICINE & PHARMACOTHERAPY
- Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development
- (2016) Chengcao Sun et al. Oncotarget
- MicroRNA (miRNA) in cancer
- (2015) Kaladhar B Reddy Cancer Cell International
- DIANA-miRPath v3.0: deciphering microRNA function with experimental support
- (2015) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein
- (2015) LEI WU et al. ONCOLOGY REPORTS
- A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
- (2015) Wenting Xu et al. Cell Adhesion & Migration
- The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence
- (2015) Keyata N. Thompson et al. Oncotarget
- Predicting effective microRNA target sites in mammalian mRNAs
- (2015) Vikram Agarwal et al. eLife
- miR-326 Targets Antiapoptotic Bcl-xL and Mediates Apoptosis in Human Platelets
- (2015) Shifang Yu et al. PLoS One
- Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
- (2015) Nicole M. Davis et al. Oncotarget
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- Breast Cancer: Epidemiology and Etiology
- (2014) ZiQi Tao et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
- (2013) Thomas W. Grunt et al. CURRENT CANCER DRUG TARGETS
- Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
- (2013) Samy Lamouille et al. CURRENT OPINION IN CELL BIOLOGY
- Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
- (2013) Shuwei Qiu et al. Journal of Translational Medicine
- Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma
- (2013) Shuai Wang et al. MEDICAL ONCOLOGY
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- miRNA Biomarkers in Breast Cancer Detection and Management
- (2012) Sidney W. Fu et al. Journal of Cancer
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- microRNAs, an active and versatile group in cancers
- (2011) Jeffrey Liu et al. International Journal of Oral Science
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- HER-2 as a Target for Breast Cancer Therapy
- (2009) M. Ignatiadis et al. CLINICAL CANCER RESEARCH
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy
- (2009) William C.S. Cho INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
- (2009) Elena López-Knowles et al. INTERNATIONAL JOURNAL OF CANCER
- miR-331-3p Regulates ERBB-2 Expression and Androgen Receptor Signaling in Prostate Cancer
- (2009) Michael R. Epis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
- (2008) Timothy A Yap et al. CURRENT OPINION IN PHARMACOLOGY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More